Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
11.56
-0.37 (-3.10%)
Sep 26, 2025, 4:00 PM EDT - Market closed
Surrozen Employees
As of December 31, 2024, Surrozen had 41 total employees, including 40 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.38% compared to the previous year.
Employees
41
Change (1Y)
-1
Growth (1Y)
-2.38%
Revenue / Employee
$307,829
Profits / Employee
-$591,780
Market Cap
99.07M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41 | -1 | -2.38% |
| Dec 31, 2023 | 42 | -32 | -43.24% |
| Dec 31, 2022 | 74 | -9 | -10.84% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SRZN News
- 23 days ago - Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Surrozen to Present at Upcoming Healthcare Investor Conference - GlobeNewsWire
- 7 weeks ago - Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway - GlobeNewsWire
- 5 months ago - Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 6 months ago - Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases - GlobeNewsWire
- 11 months ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire